Skip to main content
Erschienen in: The journal of nutrition, health & aging 1/2020

09.12.2019

SARC-F as a Useful Tool for Screening Sarcopenia in Elderly Patients with Hip Fractures

verfasst von: Y.-C. Ha, C. Won Won, M. Kim, K.-J. Chun, Jun-Il Yoo

Erschienen in: The journal of nutrition, health & aging | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

SARC-F is recommended as a sarcopenia screening tool and comprised of five assessment items: strength, assistance walking, rising from a chair, climbing stairs, and falls.

Objective

The purpose of this study was to assess whether the SARC-F questionnaire in elderly patients with hip fractures was a valid screening tool for sarcopenia by comparison of the results with criteria from the Europe, Asia, and international working groups.

Measurements

115 men and woman with hip fractures were assessed. The SARC-F self-reported questionnaire scores range from 0 to 10 and a score ≥ 4 defines sarcopenia. These survey questions were used to calculate the SARC-F score. Measurements, including appendicular muscle mass, were taken using dual-energy X-ray and grip strength using a dynamometer. Classification using the SARC-F score was compared using the consensus panel criteria from the international, European, and Asian sarcopenia working groups. The performance of all four methods was compared by examining the predictive ability using a ROC curve.

Results

A total of 115 subjects were included and the sarcopenia prevalence rate (SARC-F score ≥ 4) was 63.5 percent. The sensitivity, specificity, positive predictive value, negative predictive value PPV with the EWGSOP-2 criteria in Older People as the reference standard were 95.35 %, 56.94 %, 56.94%, 95.35%, and 71.3%, respectively. In addition, we found similar results for sensitivity and specificity as studies using the EWGSOP and AWGS criteria.

Conclusions

The SARC-F questionnaire is a useful screening tool for elderly patients with hip fractures. This finding supports the recommendation of SARC-F as a screening tool for sarcopenia from the EWGSOP2.
Literatur
1.
Zurück zum Zitat Cao L, Morley JE. Sarcopenia Is Recognized as an Independent Condition by an International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) Code. J Am Med Dir Assoc 2016;17:675–677.CrossRef Cao L, Morley JE. Sarcopenia Is Recognized as an Independent Condition by an International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) Code. J Am Med Dir Assoc 2016;17:675–677.CrossRef
2.
Zurück zum Zitat Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR et al. Epidemiology of Sarcopenia among the Elderly in New Mexico. American Journal of Epidemiology 1998;147:755–763.CrossRef Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR et al. Epidemiology of Sarcopenia among the Elderly in New Mexico. American Journal of Epidemiology 1998;147:755–763.CrossRef
3.
Zurück zum Zitat Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 2011;12:249–256.CrossRef Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 2011;12:249–256.CrossRef
4.
Zurück zum Zitat Chen L-K, Liu L-K, Woo J, Assantachai P, Auyeung T-W, Bahyah KS et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014;15:95–101.CrossRef Chen L-K, Liu L-K, Woo J, Assantachai P, Auyeung T-W, Bahyah KS et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014;15:95–101.CrossRef
5.
Zurück zum Zitat McLean RR, Kiel DP. Developing consensus criteria for sarcopenia: an update. J Bone Miner Res 2015;30:588–592.CrossRef McLean RR, Kiel DP. Developing consensus criteria for sarcopenia: an update. J Bone Miner Res 2015;30:588–592.CrossRef
6.
Zurück zum Zitat Kim S, Kim M, Won CW. Validation of the Korean Version of the SARC-F Questionnaire to Assess Sarcopenia: Korean Frailty and Aging Cohort Study. Journal of the American Medical Directors Association 2018;19:40–45.e1.CrossRef Kim S, Kim M, Won CW. Validation of the Korean Version of the SARC-F Questionnaire to Assess Sarcopenia: Korean Frailty and Aging Cohort Study. Journal of the American Medical Directors Association 2018;19:40–45.e1.CrossRef
7.
Zurück zum Zitat Woo J, Leung J, Morley JE. Validating the SARC-F: a suitable community screening tool for sarcopenia? J Am Med Dir Assoc 2014;15:630–634.CrossRef Woo J, Leung J, Morley JE. Validating the SARC-F: a suitable community screening tool for sarcopenia? J Am Med Dir Assoc 2014;15:630–634.CrossRef
8.
Zurück zum Zitat Choi HJ, Shin CS, Ha Y-C, Jang S, Jang S-M, Jang S et al. Burden of osteoporosis in adults in Korea: a national health insurance database study. J Bone Miner Metab 2012;30:54–58.CrossRef Choi HJ, Shin CS, Ha Y-C, Jang S, Jang S-M, Jang S et al. Burden of osteoporosis in adults in Korea: a national health insurance database study. J Bone Miner Metab 2012;30:54–58.CrossRef
9.
Zurück zum Zitat Lee S-R, Ha Y-C, Kang H, Park Y-G, Nam KW, Kim S-R. Morbidity and mortality in Jeju residents over 50-years of age with hip fracture with mean 6-year follow-up: a prospective cohort study. J Korean Med Sci 2013;28:1089–1094.CrossRef Lee S-R, Ha Y-C, Kang H, Park Y-G, Nam KW, Kim S-R. Morbidity and mortality in Jeju residents over 50-years of age with hip fracture with mean 6-year follow-up: a prospective cohort study. J Korean Med Sci 2013;28:1089–1094.CrossRef
10.
Zurück zum Zitat Hida T, Ishiguro N, Shimokata H, Sakai Y, Matsui Y, Takemura M et al. High prevalence of sarcopenia and reduced leg muscle mass in Japanese patients immediately after a hip fracture. Geriatr Gerontol Int 2013;13:413–420.CrossRef Hida T, Ishiguro N, Shimokata H, Sakai Y, Matsui Y, Takemura M et al. High prevalence of sarcopenia and reduced leg muscle mass in Japanese patients immediately after a hip fracture. Geriatr Gerontol Int 2013;13:413–420.CrossRef
11.
Zurück zum Zitat González-Montalvo JI, Alarcón T, Gotor P, Queipo R, Velasco R, Hoyos R et al. Prevalence of sarcopenia in acute hip fracture patients and its influence on short-term clinical outcome. Geriatr Gerontol Int 2016;16:1021–1027.CrossRef González-Montalvo JI, Alarcón T, Gotor P, Queipo R, Velasco R, Hoyos R et al. Prevalence of sarcopenia in acute hip fracture patients and its influence on short-term clinical outcome. Geriatr Gerontol Int 2016;16:1021–1027.CrossRef
12.
Zurück zum Zitat Di Monaco M, Castiglioni C, Vallero F, Di Monaco R, Tappero R. Sarcopenia is more prevalent in men than in women after hip fracture: a cross-sectional study of 591 inpatients. Arch Gerontol Geriatr 2012;55:e48–52.CrossRef Di Monaco M, Castiglioni C, Vallero F, Di Monaco R, Tappero R. Sarcopenia is more prevalent in men than in women after hip fracture: a cross-sectional study of 591 inpatients. Arch Gerontol Geriatr 2012;55:e48–52.CrossRef
13.
Zurück zum Zitat Yoo JI, Ha YC, Kwon HB, Lee YK, Koo KH, Yoo MJ. High Prevalence of Sarcopenia in Korean Patients after Hip Fracture: a Case-Control Study. J Korean Med Sci 2016;31:1479–1484.CrossRef Yoo JI, Ha YC, Kwon HB, Lee YK, Koo KH, Yoo MJ. High Prevalence of Sarcopenia in Korean Patients after Hip Fracture: a Case-Control Study. J Korean Med Sci 2016;31:1479–1484.CrossRef
14.
Zurück zum Zitat Morley JE, Cao L. Rapid screening for sarcopenia: Editorial. Journal of Cachexia, Sarcopenia and Muscle 2015;6:312–314.CrossRef Morley JE, Cao L. Rapid screening for sarcopenia: Editorial. Journal of Cachexia, Sarcopenia and Muscle 2015;6:312–314.CrossRef
15.
Zurück zum Zitat Buderer NM. Statistical methodology: I. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity. Acad Emerg Med 1996;3:895–900.CrossRef Buderer NM. Statistical methodology: I. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity. Acad Emerg Med 1996;3:895–900.CrossRef
16.
Zurück zum Zitat Bahat G, Oren MM, Yilmaz O, Kiliç C, Aydin K, Karan MA. Comparing SARC-F with SARC-CalF to Screen Sarcopenia in Community Living Older Adults. J Nutr Health Aging 2018;22:1034–1038.CrossRef Bahat G, Oren MM, Yilmaz O, Kiliç C, Aydin K, Karan MA. Comparing SARC-F with SARC-CalF to Screen Sarcopenia in Community Living Older Adults. J Nutr Health Aging 2018;22:1034–1038.CrossRef
17.
Zurück zum Zitat Barbosa-Silva TG, Menezes AMB, Bielemann RM, Malmstrom TK, Gonzalez MC, Grupo de Estudos em Composição Corporal e Nutrição (COCONUT). Enhancing SARC-F: Improving Sarcopenia Screening in the Clinical Practice. J Am Med Dir Assoc 2016;17:1136–1141.CrossRef Barbosa-Silva TG, Menezes AMB, Bielemann RM, Malmstrom TK, Gonzalez MC, Grupo de Estudos em Composição Corporal e Nutrição (COCONUT). Enhancing SARC-F: Improving Sarcopenia Screening in the Clinical Practice. J Am Med Dir Assoc 2016;17:1136–1141.CrossRef
18.
Zurück zum Zitat Tanaka S, Kamiya K, Hamazaki N, Matsuzawa R, Nozaki K, Maekawa E et al. Utility of SARC-F for Assessing Physical Function in Elderly Patients With Cardiovascular Disease. J Am Med Dir Assoc 2017;18:176–181.CrossRef Tanaka S, Kamiya K, Hamazaki N, Matsuzawa R, Nozaki K, Maekawa E et al. Utility of SARC-F for Assessing Physical Function in Elderly Patients With Cardiovascular Disease. J Am Med Dir Assoc 2017;18:176–181.CrossRef
Metadaten
Titel
SARC-F as a Useful Tool for Screening Sarcopenia in Elderly Patients with Hip Fractures
verfasst von
Y.-C. Ha
C. Won Won
M. Kim
K.-J. Chun
Jun-Il Yoo
Publikationsdatum
09.12.2019
Verlag
Springer Paris
Erschienen in
The journal of nutrition, health & aging / Ausgabe 1/2020
Print ISSN: 1279-7707
Elektronische ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-019-1307-6

Weitere Artikel der Ausgabe 1/2020

The journal of nutrition, health & aging 1/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.